Skip to content

OrderlyMeds review

Posts month-to-month cash prices for compounded GLP-1s and for Wegovy and Zepbound. The catch: FDA sent it a warning letter in June 2026, and its brand-name prices sit far above the makers' own cash programs.

Research-based review: nobody from GLPLens signed up, paid or received medication. Everything below comes from OrderlyMeds's own pages and FDA, read Sep 27, 2026. How we score.

50 / 100

What it prescribes
0 / 40 FDA warning letter about GLP-1 products (2026-06-08), not resolved
Published prices
20 / 20 Membership and medication prices published
Commitment
20 / 20 Cancel anytime
Insurance
0 / 10 Self-pay only
Where it operates
10 / 10 All 50 states

Website: orderlymeds.com. We do not link to it: it has an FDA warning letter about GLP-1 products. Brand-name options: the price table.

Good

  • Full price list, including brand-name Wegovy and Zepbound
  • Month-to-month plans with no membership fee
  • Says its providers are licensed in all 50 states
  • Names its partner pharmacies

Watch out for

  • FDA warning letter about its compounded GLP-1 marketing, not closed out
  • Brand-name prices are far above the makers' own cash programs
  • Starter discounts are for new patients at the lowest dose, paid up front
  • Does not accept insurance

What it is

OrderlyMeds is a cash-pay telehealth service that sells compounded semaglutide and tirzepatide as well as brand-name Wegovy and Zepbound [1]. FDA sent it a warning letter in June 2026 about how it marketed the compounded drugs [13]. Its plans also bundle extras such as meal plans and a patient community.

What it prescribes

Both kinds. The brand-name options are Wegovy and Zepbound pens, which are FDA-approved. The compounded options are semaglutide and tirzepatide injections, which are not: FDA does not review compounded drugs for safety, effectiveness or quality before they are sold [20]. A compounded injection is a different product from the brand-name pen. See our Wegovy and Zepbound pages for how the approved drugs compare.

What it costs

OrderlyMeds posts one monthly price per product, with no membership fee [5].

Medicine Monthly plan
Compounded semaglutide $149 [2]
Compounded tirzepatide $299 [2]
Wegovy pen $1,839 [2]
Zepbound pen $1,498 [2]

New patients can get a 2-month starter program at half price: $149 for compounded semaglutide or $299 for compounded tirzepatide [3]. The starter price is only for people starting at the lowest dose, and it is paid in full up front [4].

The brand-name prices are far above the makers’ own cash programs. LillyDirect lists Zepbound pens from $449 a month even at the top dose, for refills on time [18]. NovoCare Pharmacy lists a month of Wegovy 2.4 mg pens at $349 [19]. Check our savings check before paying more.

OrderlyMeds does not accept insurance [6]. Our coverage guide explains when a plan may pay for a brand-name drug through a regular pharmacy.

Where it operates

OrderlyMeds says its providers are licensed in all 50 states [7].

Signing up and cancelling

The service runs month to month, so you commit to one month at a time [8]. You can cancel before the doctor finalizes the prescription unless you picked a multi-month plan [9]. After the prescription is written, that order cannot be cancelled [10]. See our guide to cancelling a GLP-1 program.

Safety and regulatory record

FDA reviewed the OrderlyMeds website in March 2026 [13]. Its warning letter said the product photos carried the OrderlyMeds logo, which suggested OrderlyMeds made the drugs when it did not [14]. It also objected to the site’s claim that the drugs came from an “FDA-licensed pharmacy,” because FDA does not approve or license compounding pharmacies [15]. FDA’s database listed no close-out letter when this page was updated, so we treat the letter as open.

OrderlyMeds names ProRx among its partner pharmacies [11]. FDA sent a separate warning letter in April 2026 to ProRx LLC, which noted a recall of some compounded tirzepatide and semaglutide lots for lack of sterility assurance [16]. We could not confirm that this is the same ProRx: OrderlyMeds says all its partners are 503A pharmacies [12], while the ProRx LLC in the letter is registered as a 503B outsourcing facility [17].

Because of the letter, and because it sells compounded drugs, GLPLens does not link to OrderlyMeds.

Who it suits, and who should look elsewhere

OrderlyMeds may suit someone who wants posted month-to-month prices and a choice between compounded and brand-name drugs in one place. Look elsewhere if an open FDA warning letter concerns you, or if you want Wegovy or Zepbound at the lowest cash price. Our programs page compares brand-name prices across services.

Sources

  1. We offer brand name weight loss treatments Zepbound® (tirzepatide) and Wegovy® (semaglutide), as well as compounded medications where appropriate and prescribed. orderlymeds.com, read Sep 27, 2026.
  2. Monthly plans Compounded Tirzepatide GLP-1 injections $299 Compounded Semaglutide GLP-1 injections $149 Wegovy® (GLP-1 pen) $1,839 Zepbound® (GLP-1/GIP pen) $1,498 orderlymeds.com, read Sep 27, 2026.
  3. Compounded Tirzepatide GLP-1/GIP injections $149/mo $299 for 2 months Compounded Semaglutide GLP-1 injections $74/mo $149 for 2 months orderlymeds.com, read Sep 27, 2026.
  4. *Our starter program is only available for patients starting on the lowest dosage available. Pay upfront in full. orderlymeds.com, read Sep 27, 2026.
  5. Never pay membership fees, setup costs, or any hidden expenses that other companies might spring on you. orderlymeds.com, read Sep 27, 2026.
  6. No, we do not accept insurance. However, you can use your HSA or FSA card for payment. orderlymeds.com, read Sep 27, 2026.
  7. Our providers are licensed to prescribe medication in all 50 states. orderlymeds.com, read Sep 27, 2026.
  8. Our service is offered on a month-to-month basis, so you only commit to one month at a time and aren’t locked into a long-term financial contract. orderlymeds.com, read Sep 27, 2026.
  9. When you sign up, you can cancel any time before the doctor finalizes your prescription, unless you’ve selected a multi-month plan. orderlymeds.com, read Sep 27, 2026.
  10. Once your prescription is written after your medical consultation, cancellation is no longer possible. orderlymeds.com, read Sep 27, 2026.
  11. We currently partner with PerfectRx/PerfectionRx, ProRx, Casa, Pharmacy Hub and SmartPharmaRx. orderlymeds.com, read Sep 27, 2026.
  12. All our pharmacy partners are 503A designated. orderlymeds.com, read Sep 27, 2026.
  13. Violations were identified and documented during a review of OrderlyMeds’ website, https://orderlymeds.com, FDA Establishment Identifier (FEI) 3044027176, in March 2026. fda.gov, read Sep 27, 2026.
  14. The compounded semaglutide and tirzepatide products displayed on your website feature OrderlyMeds’ logo on the pictured label, suggesting OrderlyMeds is the compounder of those drugs when in fact it is not. fda.gov, read Sep 27, 2026.
  15. Your website claims that the compounded drug products it offers are sourced from an “FDA-licensed pharmacy.” Compounding facilities, including pharmacies and outsourcing facilities, are not “FDA-approved” or “FDA-licensed” entities. fda.gov, read Sep 27, 2026.
  16. FDA also acknowledges that, on October 15, 2025, your firm initiated a voluntary recall of Lot PRORX08062025-3 of Tirzepatide Injection 27mg/3mL, 3mL in multidose vials and various lots of Semaglutide Injection multidose vials in multiple strengths, within expiry, due to a lack of sterility assurance. fda.gov, read Sep 27, 2026.
  17. You registered your facility with the U.S. Food and Drug Administration (FDA) as an outsourcing facility under section 503B of the Federal Food, Drug, and Cosmetic Act (FDCA) fda.gov, read Sep 27, 2026.
  18. 15 mg/0.6 mL Self-pay price: Starting at $449/month* when you refill within 45 days† lilly.com, read Sep 27, 2026.
  19. Wegovy® - 2.4 mg 4 Single-Dose Prefilled Pens $349.00 $698.00 $1,047.00 novocare.com, read Sep 27, 2026.
  20. However, compounded drugs are not FDA approved. This means the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed. fda.gov, read Sep 27, 2026.

Other reviews: all programs, scored the same way. Real users' experiences: reader stories.